Skip to content

Clinical Trial of Minimally Invasive Robotic Spine Surgery

Randomized Comparative Trial of Minimally Invasive Robotic vs. Freehand in Short Adult Degenerative Spinal Fusion Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02121249
Enrollment
40
Registered
2014-04-23
Start date
2013-12-31
Completion date
2019-12-31
Last updated
2020-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Lumbar Spinal Stenosis

Brief summary

The purpose of this study was to quantify potential short- and long-term benefits of robotically-guided minimally invasive spine surgery in instrumentation of degenerative lumbar or lumbosacral spine disease in adult patients, in comparison to instrumentation in a matching cohort of control patients performed using conventional freehand technique.

Interventions

DEVICERenaissance, Mazor Robotics Ltd, Caesare, Israel

Renaissance (Mazor Robotics Ltd, Caesare, Israel) is the name of the robot

No specific device is necessary in the free hand technique

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (age from 40 years to 85 years), undergoing short (below 3 consecutive vertebrae) lumbar or lumbosacral fixation surgery. * Primary surgery and revision surgery * Patient capable of complying with study requirements * Signed informed consent of patient or legal guardian

Exclusion criteria

* Infection or malignancy * Primary abnormalities of bones (e.g. osteogenesis imperfecta) * Primary muscle diseases, such as muscular dystrophy * Neurologic diseases (e.g. Charcot-Marie Tooth, Guillain-Barre syndrome, cerebral palsy, neurofibroma) * Spinal cord abnormalities with any neurologic symptoms or signs * Spinal cord lesions requiring neurosurgical interventions, such as hydromyelia * Paraplegia * Patients requiring anterior release or instrumentation * Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study. * Patient cannot follow study protocol, for any reason * Patient (or legal guardian, when applicable) cannot or will not sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pedicle screw instrumentation accuracywithin 7 days after operationThe location of pedicle screw is evaluated by postoperative CTs in a subset of patients
Oswestry Disability Indexup to 5 year after operation, every yearHealth status

Secondary

MeasureTime frameDescription
intraoperative blood lossafter operationintraoperative blood loss
postoperative drainagewithin 3 days after operationTotal drainage after surgery
amount of transfusionwithin 7 days after operationTotal transfusion during and after surgery
time to ambulationwithin 3 days after operationimmediate postop to ambulation start
Fusion ratesup to 5 year after operationThis is assessed by postoperative computed tomography at 1 year after surgery
Visual Analog Pain Scaleup to 5 year after operation, every yearPain status
SF-36up to 5 year after operation, every yearHealth status
Radiographic adjacent level degenerationup to 5 year after operation, every yearRadiographic changes according to UCLA, vertebral body translation, motion change, segmental kyphosis or lordosis, disc height changes
Change of Oswestry Disability Indexup to 5 year after surgery, every yearHealth status
Operation durationAfter operationIntraoperative time

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026